Journal article icon

Journal article

Characterization of patient-derived site-specific in vivo models of pediatric-type diffuse high-grade glioma using magnetic resonance imaging

Abstract:
Background: There is an urgent need for novel targeted therapeutic strategies for pediatric-type diffuse high-grade glioma (PDHGG) to improve patient outcomes, the development of which demands model systems that accurately recapitulate the specific PDHGG subtypes. Characterization, longitudinal monitoring and, ultimately, evaluation of treatment response in these models requires sensitive non-invasive imaging techniques such as magnetic resonance imaging (MRI). Methods: Thirty-five patient-derived, site-specific, orthotopic in vivo models of PDHGG, established using implantation of patient tumor material or patient-derived in vitro cultures maintained in stem cell retaining conditions, were characterized using multiparametric MRI. Results: Median survival ranged from 54 to 433 days. Tumors identified on T2-weighted (T2w) images varied in appearance from a diffuse hyperintense signal to well-defined high contrast masses, and distribution of human nuclear antigen positive tumor cells corresponded to regions of T2w signal hyperintensity. Apparent diffusion coefficient was significantly higher in brainstem diffuse midline glioma (DMG) models than in diffuse hemispheric glioma (DHG) tumors, mirroring clinical observations. Lack of contrast-agent enhancement indicated an intact blood-brain barrier in most models, with heterogeneous disruption observed in four DHG models. Upon re-implantation, survival was significantly shortened in 3/4 DHG tumors and 1/10 DMG models, while quantitative MRI parameters remained similar. Furthermore, when 3 models grown in 2D and 3D in vitro were implanted in parallel, poorer survival or improved penetrance was associated with 3D cultures. Conclusion: We established a comprehensive pre-clinical platform in which to evaluate the efficacy of therapeutic strategies against PDHGG in vivo, enhanced by the use of multiparametric MRI.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1093/noajnl/vdag049

Authors

More by this author
Role:
Author
ORCID:
0000-0002-3990-9663


More from this funder
Funder identifier:
https://ror.org/054225q67
Grant:
C16412/A27725
More from this funder
Funder identifier:
https://ror.org/04bac6g30
Grant:
16-234
More from this funder
Funder identifier:
10.13039/501100023479
More from this funder
Funder identifier:
https://ror.org/01k33dw46


Publisher:
Oxford University Press
Journal:
Neuro-Oncology Advances More from this journal
Volume:
8
Issue:
1
Pages:
vdag049
Article number:
vdag049
Publication date:
2026-02-27
Acceptance date:
2026-02-21
DOI:
EISSN:
2632-2498
ISSN:
2632-2498


Language:
English
Keywords:
Pubs id:
2389806
Local pid:
pubs:2389806
Source identifiers:
3893356
Deposit date:
2026-03-27
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP